Medpace MEDP 深 沪
已收盘 10-09 16:00:00 美东时间
612.05
+9.350
+1.55%
华盛通- 最 高620.25
- 今 开602.70
- 成交量 15.98万股
- 最 低 602.70
- 昨 收 602.70
- 总市值 170.83亿
- 52周最高 677.90
- 市盈率 静 40.06
- 换手率 0.57%
- 52周最低 373.00
- 委 比 93.04%
- 总股本 2791.17万
- 历史最高 677.90
- 量 比 0.62
- 振 幅 2.91%
- 历史最低 21.76
- 每 手 1
- 风险率 67.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多机构：海外CXO板块整体呈现"需求回暖、订单修复、预期上修"的积极信号
10月9日，中邮证券发布了一篇医药生物行业的研究报告，报告指出，从CRL、IQV、TMO看龙头CXO公司的AI观（及全球CXO2026中报业绩跟踪）。 国际头部...
10-09 10:31
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 10 Years
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 21.36% on an annualized basis producing an average annual return of 35.2%. Currently, Medpace Holdings has a market capitalization of $17.32 billion. Buying $100 In MEDP: If an investor had bought $100 of MEDP stock...
10-06 23:15
Newegg, Medpace, Compass, Spyre, MINISO Insider Shake-Up
Insiders have been trading these 5 stocks: (($NEGG)), (($MEDP)), (($CMPX)), (($...
10-03 21:01
美股大行评级 | 潜在涨幅600.93%！Ascendiant Capital上调Aytu BioPharma目标价至15美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14.5美元升至15美元；摩根大通：维持Annexon"超配"评级，目标价从14美元升至15美元
10-01 19:18
UBS Upgrades Medpace Holdings to Neutral, Raises Price Target to $673
UBS analyst Kevin Caliendo upgrades Medpace Holdings (NASDAQ:MEDP) from Sell to Neutral and raises the price target from $405 to $673.
10-01 00:01
盟科药业披露美国子公司诉讼进展 被告Medpace提出反诉
登录新浪财经APP 搜索【信披】查看更多考评等级 9月25日，盟科药业发布公告披露其美国全资子公司相关合同纠纷的最新进展，此前盟科美国起诉C...
09-24 19:26
Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 15.31% on an annualized basis producing an average annual return of 26.82%. Currently, Medpace Holdings has a market capitalization of $16.58 billion. Buying $100 In MEDP: If an investor had bought $100 of MEDP stock...
09-12 00:00
If You Invested $1000 In Medpace Holdings Stock 10 Years Ago, You Would Have This Much Today
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 22.9% on an annualized basis producing an average annual return of 36.28%. Currently, Medpace Holdings has a market capitalization of $17.14 billion. Buying $1000 In MEDP: If an investor had bought $1000 of MEDP sto...
08-26 23:00
If You Invested $100 In Medpace Holdings Stock 5 Years Ago, You Would Have This Much Today
Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 14.56% on an annualized basis producing an average annual return of 26.38%. Currently, Medpace Holdings has a market capitalization of $16.15 billion. Buying $100 In MEDP: If an investor had bought $100 of MEDP stock...
08-15 07:00
Wall Street Analysts Are Neutral on Top Healthcare Picks
Analysts fell to the sidelines weighing in on Novo Nordisk (NVO) and Medpace Ho...
07-28 21:00
